NPS Pharmaceuticals Announces Exercise of Over-Allotment Option and …

The total number of shares sold was 6,900,000, comprised of 6,000,000 shares of common stock initially offered and an additional 900,000 shares of common stock sold pursuant to the underwriters' exercise of their over-allotment option, at the public …
See all stories on this topic »